Skip to main content

Advertisement

Log in

Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

Although human immunodeficiency virus (HIV) clade C virus infects the largest populations worldwide, to date there are no prospective studies reported thus far to determine the incidence or prevalence of HIV dementia in this population. HIV clade C virus is a CCR5-tropic virus and thus predominantly infects macrophages, which are the key cells implicated in the pathogenesis of HIV dementia. However, HIV dementia has only rarely been reported in these populations. The authors thus used a recently developed International HIV Dementia Scale (IHDS) to screen a well-characterized cohort of HIV-infected discordant couples in Pune, India. 48 HIV+ subjects with CD4 cell count <200 cells/mm3 and 48 HIV− subjects were studied. The HIV+ subjects had significantly lower IHDS scores compared to the HIV− subjects. 35% of the HIV+ subjects and 15% of the HIV− subjects scored <10 on the IHDS. These observations suggest that the prevalence of HIV dementia may be higher in this population than previously reported. More importantly, it demonstrates that the IHDS can be used as a screening tool in the Indian population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albright AV, Shieh JTC, Itoh T, Lee B, Pleasure D, O’Connor MJ, Doms RW, Gonzalez-Scarano F (1999). Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73: 205–213.

    PubMed  CAS  Google Scholar 

  • Chiesi A, Seeber AC, Dally LG, Floridia M, Rezza G, Vella S (1996). AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection. J Neurol Sci 144: 107–113.

    Article  PubMed  CAS  Google Scholar 

  • McArthur J, Brew B, Nath A (2005). Neurological complications of HIV infection. Lancet Neurol 4: 543–555.

    Article  PubMed  Google Scholar 

  • McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003). Human immunodeficiency virus-associated dementia: an evolving disease. J NeuroVirol 9: 205–221.

    PubMed  CAS  Google Scholar 

  • Power C, Selnes OA, Grim JA, McArthur JC (1995). HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8: 273–278.

    Article  PubMed  CAS  Google Scholar 

  • Sacktor N (2002). The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2): 115–121.

    Article  PubMed  CAS  Google Scholar 

  • Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.

    PubMed  CAS  Google Scholar 

  • Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8: 136–142.

    Article  PubMed  Google Scholar 

  • Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005). The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19: 1367–1374.

    PubMed  Google Scholar 

  • Shankar SK, Mahadevan A, Satishchandra P, Kumar RU, Yasha TC, Santosh V, Chandramuki A, Ravi V, Nath A (2005). Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 121: 468–488.

    PubMed  CAS  Google Scholar 

  • Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG (2003). Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 51: 229–240.

    Article  PubMed  CAS  Google Scholar 

  • Teja VD, Talasila SR, Vemu L (2005). Neurologic manifestations of HIV infection: an Indian hospital-based study. AIDS Read 15: 139–143, C3.

    PubMed  Google Scholar 

  • Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Fantoni M, Sampaolesi A, Noto P, Ippolito G, Wu AW (2004). Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS 15: 254–259.

    Article  PubMed  CAS  Google Scholar 

  • Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001). Neurological manifestations of HIV disease. J Assoc Physicians India 49: 343–348.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Nath.

Additional information

Supported by a grant from NIH (R21MH071213).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riedel, D., Ghate, M., Nene, M. et al. Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. Journal of NeuroVirology 12, 34–38 (2006). https://doi.org/10.1080/13550280500516500

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280500516500

Keywords

Navigation